icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
TLR-7 agonist GS-9620 can improve HBV-specific T cell and NK cell responses in
nucleos(t)ide suppressed patients with chronic hepatitis B

 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Carolina Boni1, Andrea Vecchi1, Marzia Rossi1, Diletta Laccabue1, Tiziana Giuberti1, Arianna Alfieri1, Pietro Lampertico2, Glenda Grossi2, Floriana Facchetti2, Maurizia R. Brunetto3, Barbara Coco3, Daniela Cavallone3, Alessandra Mangia4, Rosanna Santoro4, Anuj Gaggar5, G Mani Subramanian5, Carlo Ferrari1
 
1.Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda-Ospedaliero-Universitaria of Parma, Parma, Italy
2.Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Universitą degli Studi di Milano, Italy
3.Hepatology Unit and Liver Physiopathology Laboratory, University Hospital of Pisa, Italy 4.Liver Unit, IRCCS, "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy 5.Gilead Sciences, Inc. Foster City, CA, United States

HCV1

HCV2

 

HCV3

HCV4

HCV5

HCV6

HCV7

HCV8

HCV9

HCV10

HCV11

HCV12

HCV13

HCV14

HCV15

HCV16

HCV17

HCV18